Correlation Between Citigroup and Acasti Pharma
Can any of the company-specific risk be diversified away by investing in both Citigroup and Acasti Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and Acasti Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citigroup and Acasti Pharma, you can compare the effects of market volatilities on Citigroup and Acasti Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of Acasti Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and Acasti Pharma.
Diversification Opportunities for Citigroup and Acasti Pharma
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Citigroup and Acasti is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and Acasti Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acasti Pharma and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with Acasti Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acasti Pharma has no effect on the direction of Citigroup i.e., Citigroup and Acasti Pharma go up and down completely randomly.
Pair Corralation between Citigroup and Acasti Pharma
Taking into account the 90-day investment horizon Citigroup is expected to generate 0.39 times more return on investment than Acasti Pharma. However, Citigroup is 2.56 times less risky than Acasti Pharma. It trades about 0.14 of its potential returns per unit of risk. Acasti Pharma is currently generating about 0.04 per unit of risk. If you would invest 3,789 in Citigroup on August 29, 2024 and sell it today you would earn a total of 3,227 from holding Citigroup or generate 85.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 92.44% |
| Values | Daily Returns |
Citigroup vs. Acasti Pharma
Performance |
| Timeline |
| Citigroup |
| Acasti Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
OK
Citigroup and Acasti Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Citigroup and Acasti Pharma
The main advantage of trading using opposite Citigroup and Acasti Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, Acasti Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acasti Pharma will offset losses from the drop in Acasti Pharma's long position.| Citigroup vs. JPMorgan Chase Co | Citigroup vs. Wells Fargo | Citigroup vs. Toronto Dominion Bank | Citigroup vs. Nu Holdings |
| Acasti Pharma vs. Tonix Pharmaceuticals Holding | Acasti Pharma vs. Jaguar Animal Health | Acasti Pharma vs. Ibio Inc | Acasti Pharma vs. Akari Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |